Topical ceftazidime and vancomycin for surgical wound infection

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Jul 2026: Trial started, NCT07934199
  2. 12 Nov 2026: Trial registered, NCT07934199

The trials

NCT07934199: Ceftazidime Safety and Efficacy in the Prevention of Surgical Site Infections

State
Under way
Phase
Phase 2
People
80 planned
Started
7 Jul 2026
Primary completion
Jul 2030
Arms
Intrawound antibiotics
Results
None posted
  1. 7 Jul 2026: Trial started
  2. 12 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.